P rimary pontine hemorrhage (PPH) is the most devastating type of intracranial hemorrhage (ICH), with an acute mortality ranging from 30% to 60%. [1] [2] [3] Various factors including coma at admission, location, and volume of the hematoma were found to associate with these diverse outcomes. However, inconsistent predictors were reported when different parameters and populations were brought into analysis. [4] [5] [6] [7] As a corollary, it would make cogent sense by combining significant factors into a grading scale to enhance predictive power and, meanwhile, provide a useful tool for physicians in decision-making when facing such patients. 8 Currently, there is no standard, widely accepted early prognostic model or clinical grading scale for outcome prediction in PPH patients. The ICH score, composed of age, Glasgow Coma Scale (GCS), infratentorial origin, intraventricular hemorrhage, and hemorrhage volume, has been widely validated in predicting acute mortality, as well as long-term functional outcome in spontaneous ICH.
of hemorrhage volume and GCS in the ICH score may not be appropriate to PPH either. Overall, the predictive value of ICH score in PPH patients is decreased. 13 Researchers from Japan have tried to establish a grading scale (PPH score) for PPH patients. 14 However, in their model, continuous variables such as GCS and hematoma volume were predefined as binary variables, which may have influence on independent factor screening. In addition, the PPH score lacks external validation.
In this study, we aimed to develop and validate a new clinical grading scale for rapid and accurate assessment of PPH patients on admission. To support our findings, the performance of our grading scale was compared with the ICH score and the PPH score.
Methods

Ethic Statement
The study proposal was approved by the Medical Ethics Committees of Nanfang Hospital. For patients whose records were retrospectively reviewed, informed consents were waived because of the purely observational nature and harmlessness to patients. For patients prospectively recruited, informed consents were obtained. This study has been registered on the Chinese Clinical Trial Registry (unique identifier: ChiCTR-OOC-14005533).
Patient Selection
To develop a new grading scale, we retrospectively reviewed 276 consecutive patients with first-ever pontine hemorrhage admitted to 3 teaching hospitals (Nanfang Hospital, Southern Medical University; Zhujiang Hospital, Southern Medical University; and The Second Affiliated Hospital of Guangzhou Medical University) in southern China from January 2005 to January 2012. The inclusion criterion was a diagnosis of pontine hemorrhage verified by computer tomography (CT) and admitted within 24 hours after symptoms onset. Patients aged <18 or >80 years, with end-stage malignant diseases, with hemorrhage involving cerebellum, secondary to head trauma, bleeding diathesis, a cavernous hemangioma, or an arteriovenous malformation were excluded.
Candidate Variables
Aiming to provide a simple grading scale for early prediction, we selected potential predictors that could be easily acquired within 24 hours after admission. [4] [5] [6] [7] Medical records were carefully reviewed by using a structured data collection form to obtain the following parameters: age, sex, hypertension, diabetes mellitus, smoking, alcohol abuse, surgery (craniotomy or CT-guided stereotactic hematoma aspiration), extraventricular drainage, and need for mechanical ventilation. Physiological parameters including temperature, systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate, respiratory rate (ventilated or not), serum white blood cell count, hemoglobin, platelet count, hematocrit, prothrombin time, activated partial thromboplastin time, urea, creatinine, and serum glucose level were the initial records at admission. GCS score was extracted from the first neurological examination.
All cases included underwent cranial CT scans within 24 hours after the onset, and CT images were reviewed by 2 blinded neurologists. The location of hematoma was classified into 4 types according to Chung and Park 15 : the massive type with hematomas occupying both the basis pontis and the tegmentum bilaterally; the bilateral tegmental type with hematomas occupying the bilateral tegmentum only; the basal-tegmental type with hematomas occupying the junction between the basis pontis and the tegmentum bilaterally; and the small unilateral tegmental type with hematomas located exclusively in the unilateral tegmentum. The volume of hematoma was measured with the ABC/2 method, where A is the greatest hemorrhage diameter by CT, B is the diameter 90 degrees to A, and C is the approximate number of CT slices with hemorrhage multiplied by the slice thickness. 16 Patients with intraventricular extension, hydrocephalus, and extrapontine extension into midbrain, medulla, or both were also recorded.
Outcome Evaluation
Primary end points were 30-day mortality and 90-day functional outcome. Functional outcome was measured by modified Rankin Scale, with modified Rankin Scale score of 0 to 3 regarded as good and 4 to 6 as poor outcome. Information on survival and functional outcome were obtained from family members through telephone interviews by a trained neurologist blinded to study data.
Development of the New PPH Score
Categorical variables were compared using the 2-sided χ 2 analysis or Fisher exact test, whereas continuous variables were compared using the 2-sided Student's t test or Mann-Whitney U test, as appropriate. Factors that showed significance in univariate analysis were drawn into stepwise, forward logistic regression to identify their independent association with 30-day mortality. Cutoff points of the variables were determined by receiver operating characteristic curve analysis, and certain points were assigned to these predictors to produce a simple and intuitive grading scale, named the new PPH score (for differentiation from the previous PPH score 14 ).
Validation of the New PPH Score
To validate the new PPH score, we prospectively recruited PPH patients from 10 territory hospitals between December 2014 and November 2015 (Table I in the online-only Data Supplement) and followed the same inclusion and exclusion criteria as stated earlier.
Relevant demographic, clinical, and radiological data were recorded in case report forms. The performance of the new PPH score was presented as discrimination and calibration in terms of 30-day mortality and 90-day good outcome, measured by area under the curve (AUC) of the receiver operating characteristic curve 17 and HosmerLemeshow goodness-of-fit test, 18 respectively. To support our findings, AUC of the new PPH score was compared with that of the ICH score 9 and the PPH score, 14 using the Hanley and McNeil method. 19 In addition, Youden index (max [sensitivity+specificity−1]) was identified to denote each scale's optimal predictive cutoff value, sensitivity, and specificity.
All statistical analyses were performed using the SPSS 20.0 (IBM Institute, Inc, Chicago, IL). A significant level was established at P<0.05. 
Results
Development of the New PPH Score
A total of 171 patients (45 female) who met the criteria were regarded as available ( Figure I in the online-only Data Supplement). Data were missing in 4 (2.3%) patients for complete blood counts, in 8 (4.7%) for serum biochemistry, and in 17 (9.9%) for clotting time. The mean hemorrhage volume was 6.8±5.8 mL, with 57 (33.3%) patients having CT evidences of hemorrhage extension into the midbrain, 15 (8.8%) into the medulla, and 17 (9.9%) into the thalamus. At 30 days, 68 (39.8%) patients died and 74 (43.3%) patients had good outcome. Univariate analysis showed that the following variables were associated with 30-day mortality in patients with PPH: extraventricular drainage, need for mechanical ventilation, temperature, pulse pressure, heart rate, white cell count, serum creatinine, arterial PH value, serum glucose level, GCS, hemorrhage types, hemorrhage volume, intraventricular extension, hydrocephalus, and extrapontine extension (Table 1) . Logistic regression was performed on these parameters except for the extraventricular drainage and need for mechanical ventilation because they were not always performed within 24 hours after admission. It was found that GCS and PPH volume were independently associated with 30-day mortality (Table 2) . Cutoff values were determined by receiver operating characteristic curve analysis, and certain points were assigned to these predictors to produce a simple and intuitive grading scale, the new PPH score (Table 2) . Thirty-day mortality rates for patients with new PPH scores of 0, 1, 2, 3, and 4 were 2.7%, 31.6%, 42.7%, 81.8%, and 100%, respectively.
Validation of the New PPH Score
To validate the new PPH score, we prospectively recruited 98 patients from 10 tertiary hospitals between December 2014 and November 2015 ( Figure II in the online-only Data Supplement). The baseline characteristics of this study cohort were listed in the Table 3 . Of them, 33 (33.7%) patients died within 30 days and 50 (51.0%) patients achieved good outcome at 90 days. The median points in the nonsurvival group of the new PPH score, ICH score, and PPH score were all significantly higher than those in the survival group (all P<0.001).
Receiver operating characteristic results revealed that the new PPH score was discriminative in predicting both 30-day mortality and 90-day good outcome (Figure and Table 4) , with AUCs significantly greater than the ICH score (z value of 3.14 and 1.99; P value of 0.002 and 0.046) and the PPH score (z value of 3.74 and 2.49; P value of <0.001 and 0.013). To obtain the strongest power of prediction, cutoff values were set at 1.5 for the new PPH score, 1.5 for the ICH score, and 0.5 for the PPH score in both mortality and good outcome (Table 4) . Results showed that the new PPH score had greatest specificity and Youden index, whereas the ICH score had the highest sensitivity.
Early do not resuscitate orders and withdrawal of treatment could lead to self-fulfilling prophecy. 20 Do not resuscitate order was not signed in any cases in this study, but 13 (39.4%) patients died after withdrawal of treatment. To eliminate the impact brought by withdrawal of treatment, we verified the new PPH score in patients whose aggressive care was pursued and found that it still had strong power in predicting both 30-day mortality (AUC 0.879) and 90-day good outcome (AUC 0.910).
Because only 30-day mortality were given by all the 3 grading scales, calibration of these scales were checked on 30-day mortality here. As shown in Table 5 , Hosmer-Lemeshow χ 2 statistics was 1.378 (P=0.846, df=4) for the new PPH score, 1.491 (P=0.684, df=3) for the ICH score, and 2.831 (P=0.418, df=3) for the PPH score, indicating that all the 3 grading scales had good calibration.
Discussion
PPH is highly fatal, with an overall mortality rates of 39.8% and 33.7% in this study. Continuous and numerous efforts have been made for PPH patients, and the developments in neurological critical care have undoubtedly improved outcomes. 21, 22 However, insufficient evidences could be found to prove the superiority of surgery over conservative treatment, making accurate outcome prediction a critical issue for conveying precise information to the families and establishing a reasonable therapeutic approach. In the present study, we developed and validated a simple grading scale, the new PPH score, for 30-day mortality and 90-day functional outcome prediction in patients with PPH. Moreover, the new PPH score seemed to have higher discrimination and calibration than the ICH score and the PPH score in our study cohort.
In accordance with the findings from infratentorial-only patients in the original ICH score, 9 GCS and hematoma volume were the only 2 significant predictors identified in the present study. The ICH score, however, is limited in identifying diverse outcomes of patients having infratentorial hemorrhage because the infratentorial origin was deemed as an independent factor indicating poor outcome. Being different from supratentorial hemorrhage, the PPH volume is smaller, but conscious disturbance caused by impairment to the ascending reticular activating system is more common. Thus, we stratified both the GCS and PPH volume into 3 scales according to prior studies and our own findings. [4] [5] [6] 14 From our observation, patients with PPH volume <5 mL had a big chance to survive, whereas those with PPH volume >10 mL tended to die at early stage. For PPH volumes between 5 and 10 mL, patients with GCS score of 3 to 4 were highly fatal, whereas those with GCS score of 8 to 15 were more likely to experience functional recovery than those with a score of 5 to 7.
In this study, patients with small unilateral tegmentum hemorrhage seemed to experience better outcome than those with the other types, but no statistical significance emerged from logistic regression. The reasonable explanation was that hematoma of small unilateral tegmental type showed significantly lower size, whereas the latter was more relevant to outcome.
5,7 Intraventricular hemorrhage was not an independent predictor in this study, although it has been commonly related to poor outcome in supratentorial hemorrhage. 23, 24 It was plausible that the intraventricular hemorrhage was collinear to the location and size of the hematoma, which revealed deeper connection with outcome. In addition, intraventricular extension of infratentorial hemorrhage might reduce the oppression to parenchyma. As shown in this and several previous studies, PPH seems to occur at a younger stage than does overall ICH. 7, 25, 26 Consistently, we found no correlation between mortality and age. [4] [5] [6] 9 The implications of our findings are tempered by several limitations. First, to create a useful tool in early prediction at the bedside, we selected parameters that could be acquired within 24 hours after admission. Consequently, some factors that related to prognosis may not be recognized. Nonetheless, the predictors identified in the present study were in line with 2 notable studies.
9,27 Second, we categorized predictors based on our own findings and other studies. Given the success of grading scales using similar stratification, such as the ICH score, our decision to treat variables in this manner might be erred on the side of being more convenient. Third, in developing the new PPH score, we retrospectively recruited patients during a relatively long period of 7 years to ensure enough sample size. However, the 30-day mortality was close to that in our prospective data, and no difference was found between the first and the last recruitment years.
Accurate outcome prediction in critically ill neurological patients is necessary to distinguish who would benefit from special care or who should limit the usage of medical resources. We hope that the new PPH score identified in the present study, simply with 2 variables, will contribute to resources allocation and individual management.
Sources of Funding
This work is supported by the National Natural Science Foundation of China (No. 81271521 and 81471339).
Disclosures
None.
